| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 2,351 | 2,351 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| BLACKROCK ENT INT | 2017-06 | PURCHASE | 2018-05 | 18,045 | 19,792 | -1,747 | ||||
| TEKLA HEALTHCARE INVS | 2018-06 | PURCHASE | 2018-09 | 32 | 32 | |||||
| ADVENT CLAYMORE CV | 2015-02 | PURCHASE | 2018-08 | 8 | 8 | |||||
| PFIZER | 2015-12 | PURCHASE | 2018-11 | 6,184 | 4,763 | 1,421 | ||||
| TEKLA HEALTHCARE | 2016-04 | PURCHASE | 2018-12 | 15 | 15 | |||||
| JPMORGAN CHASE | 2017-01 | PURCHASE | 2018-03 | 63 | 5 | 58 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 214 EXXON | 9,393 | 14,593 |
| BLACKROCK RES & COM | 21,210 | 15,909 |
| SPDR S & P INTER | 19,925 | 14,152 |
| ADVENT CLAYMORE | 15,685 | 12,653 |
| PFIZER | 10,511 | 13,968 |
| CALAMOS GLOBAL | ||
| ABBVIE INC | ||
| DOW CHEMICAL | ||
| TEKLA HEALTH CARE | 24,324 | 18,058 |
| BM | 19,357 | 13,868 |
| COHEN & STEERS MLP | 18,496 | 13,129 |
| BLACKROCK EN INT DIV | 116 | 96 |
| RIO TINTO PLC | 17,798 | 15,271 |
| Description | Amount |
|---|---|
| RASSET ADJUSTMENT BY MS | -4,250 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT TAXES/LICENSES | 143 |